Could Ivermectin be an effective antiviral against SARS-CoV-2?
A double-blind, randomized, placebo-controlled clinical trial has recently demonstrated that Ivermectin, an anti-parasitic drug, can reduce in-hospital mortality rate of COVID-19 patients.
View ArticleNew evidence supports ivermectin use in children weighing less than fifteen...
Millions of children weighing less than 15kg are currently denied access to Ivermectin treatment due to insufficient safety data being available to support a change to the current label indication.
View ArticleResearchers examine whether community administration of ivermectin influences...
Researchers from the LSTM based Cochrane Infectious Disease Group explored whether community administration of ivermectin influences malaria transmission.
View ArticleWHO and Sanofi sign new agreement to sustain specific efforts to eliminate NTDs
The World Health Organization (WHO) and Sanofi – one of the world's leading pharmaceutical companies – have signed a new agreement for donations of medicines to sustain specific efforts to eliminate...
View ArticleResearchers receive NIH grants to develop new treatments for neglected...
Researchers at Washington University School of Medicine in St. Louis have received two grants from the National Institutes of Health totaling more than $5.5 million to develop new treatments for two...
View ArticleNew drug targeting LF and onchocerciasis begins its first in human trial in...
A new drug developed by an LSTM led partnership, which targets the neglected tropical diseases lymphatic filariasis and onchocerciasis has begun its first in human trial.
View ArticleQ&A: COVID-19 pandemic has widened gender inequities in health
Health inequalities facing women and girls, already stark before the onset of COVID-19, have widened glaringly during the pandemic. Lockdowns restricted access to sexual and reproductive health...
View ArticleUSF technology identifies locations of mosquitoes and helps eradicate malaria
Following his success eradicating a major source of malaria, technology created by a University of South Florida public health researcher is being implemented by insect control agencies throughout...
View ArticleIvermectin is ineffective in non-severe COVID-19 patients according to new study
A new study evaluated the effect of ivermectin on time to recovery from coronavirus disease 2019 (COVID-19) in patients with mild to moderate disease.
View ArticleUniversity Hospital Bonn coordinates eWHORM project to combat worm infections...
African and European partners join forces to enable the World Health Organisation's (WHO) "Road Map for Neglected Tropical Diseases" (NTDs) and reduce the burden of disease associated with worm...
View ArticleDoxycycline shows promise in reducing deaths and seizures from nodding syndrome
A new study suggests that a course of the drug doxycycline can decrease acute seizure-related hospitalization and deaths related to nodding syndrome.
View ArticleNiger becomes first African country to eliminate onchocerciasis
The World Health Organization (WHO) congratulates Niger for having met the criteria for onchocerciasis elimination, making it the fifth country globally and the first country in Africa to be...
View ArticleAnti-parasitic drug could accelerate the elimination of infection endemic to...
Tens of millions of people in Africa are infected by parasitic worms that cause lymphatic filariasis (also called elephantiasis), a disease that leads to severe swelling and deformities of the limbs...
View ArticleSenegal becomes ninth African country to eliminate trachoma
The World Health Organization (WHO) has validated Senegal as having eliminated trachoma as a public health problem. Senegal becomes the ninth country in WHO's African Region to have achieved this feat.
View ArticleIvermectin mass treatment shows great promise in reducing malaria transmission
Ivermectin administered to the whole population significantly reduces malaria transmission, offering new hope in the fight against the disease.
View ArticleClinical trial confirms ivermectin safety in very young children down to 5 kg
Millions of very young children currently excluded from treatment with the drug ivermectin could be safely included in ongoing campaigns against challenging and often neglected tropical diseases such...
View ArticleEnding human bait practices in river blindness monitoring
New research shows that it's possible to end the practice of using people as 'human bait' to catch and test the blackflies that spread river blindness (onchocerciasis).
View Article